SAC Capital Advisors LP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 143 filers reported holding CLOVIS ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
SAC Capital Advisors LP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2014$31,742,000
-54.9%
458,238
-60.7%
0.16%
-59.6%
Q4 2013$70,317,000
+6.4%
1,166,700
+7.3%
0.41%
+14.0%
Q3 2013$66,091,000
+42.2%
1,087,375
+56.7%
0.36%
+40.4%
Q2 2013$46,466,000693,7290.26%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2014
NameSharesValueWeighting ↓
Versant Venture Management, LLC 407,416$14,259,560,0008.34%
Palo Alto Investors LP 3,547,719$124,170,0006.91%
Antipodean Advisors LLC 1,268,658$44,403,0006.48%
Redmile Group, LLC 1,795,936$62,858,0004.70%
HealthCor Management, L.P. 1,525,000$53,375,0003.24%
PointState Capital LP 3,503,900$122,637,0003.12%
NEA Management Company, LLC 1,139,890$39,896,0002.54%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 612,500$21,438,0002.44%
PFM Health Sciences, LP 2,078,440$72,745,0002.21%
Partner Investment Management, L.P. 35,300$1,236,0002.03%
View complete list of CLOVIS ONCOLOGY INC shareholders